D. Ricciardulli

A Randomized, Double-Blind Trial on the Use of a Triple Combination Including Nevirapine, a Nonnucleoside Reverse Transcriptase HIV Inhibitor, in Antiretroviral-Naive Patients With Advanced Disease

Marco Floridia, Raffaella Bucciardini, D. Ricciardulli et al. · Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology · 1999 · 55 citations

Medicine, Pharmacology, Pharmacotherapy +17

Quality of life outcomes of combination zidovudine–didanosine–nevirapine and zidovudine–didanosine for antiretroviral-naive advanced HIV-infected patients

Raffaella Bucciardini, Albert W. Wu, Marco Floridia et al. · AIDS · 2000 · 28 citations

Pharmacy, Pharmacotherapy, Clinical Pharmacology +16

Risk factors and occurrence of rash in HIV‐positive patients not receiving nonnucleoside reverse transcriptase inhibitor: data from a randomized study evaluating use of protease inhibitors in nucleoside‐experienced patients with very low CD4 levels (<50 cells/mμL)

Marco Floridia, Raffaella Bucciardini, Vincenzo Fragola et al. · HIV Medicine · 2004 · 20 citations

Medicine, Infectious Diseases, Pharmacology +17

Plasma HIV-1 copy number and in vitro infectivity of plasma prior to and during combination antiretroviral treatment1

Stefano Vella, Giacomo Giannini, Maria Franca Pirillo et al. · Antiviral Research · 2000 · 15 citations

Life Sciences, Infectious Diseases, Molecular Biology +13

Hospitalizations and Costs of Treatment for Protease Inhibitor-Based Regimens in Patients with Very Advanced HIV-Infection (CD4 < 50/mm³)

Macro Florida, Maurizio Massella, Raffaella Bucciardini et al. · HIV Clinical Trials · 2000 · 11 citations

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17